Imagine a world where life-saving medication doesn’t cost an arm and a leg , or in this case, an insulin pen. California just said “enough” to pharmaceutical price gouging and is launching its own affordable insulin for just $11 a pop. 🤯

Breaking the Pharma Monopoly

Governor Gavin Newsom isn’t just talking the talk; he’s walking the walk. By partnering with Civica Rx, a nonprofit drug manufacturer, California is becoming the first state to essentially create its own insulin brand. Starting January 1, 2026, Californians can access CalRx® insulin glargine pens at a fraction of the current market price.

Why This Matters

Diabetes patients have long been held hostage by astronomical insulin prices. No one should have to choose between buying medication or paying rent. This move isn’t just about affordability; it’s a giant middle finger to a system that prioritizes corporate profits over human lives.

A Model for the Nation

Newsom’s bold strategy goes beyond California. By proving that affordable, accessible healthcare is possible, the state is challenging the entire pharmaceutical industry’s status quo. Other states might just follow suit, potentially sparking a nationwide revolution in drug pricing.

As Newsom bluntly put it: “California didn’t wait for the pharmaceutical industry to do the right thing , we took matters into our own hands”. Preach, Governor! 👏